BRAF and metastatic melanoma: Before 2017, the keywords that popped up were individual, mice, of the literature, vemurafenib, ras mutation, metastatic melanoma, dabrafenib, Raf inhibitor, tissue, BRAF inhibitor and braf are mostly related to mechanism therapy and prognosis.